摘要
淋巴结内免疫治疗（intralymphatic immunotherapy,ILIT）是针对变应性疾病的病因治疗,其疗效肯定、安全性高,与传统的特异性免疫治疗方法（如皮下免疫治疗和舌下免疫治疗）相比疗程明显缩短.本综述就近几年ILIT相关研究进展作一综述.
Intralymphatic immunotherapy （ILIT） is an effective and safe causative treatment for allergic diseases. Compared with conventional specific immunotherapy such as subcutaneous immunotherapy （SCIT） and sublingual immunotherapy （SLIT）, ILIT could significantly reduce treatment duration. This article will review the results of previous researches focusing on ILIT.
作者
荣翎均
郑军
郎金琦
孟粹达
Rong Lingjun;Zheng Jun;Lang Jinqi;Meng Cuida(Department of Otorhinolaryngology Head and Neck Surgery,China-Japan Union Hospital of Jilin University,Changchun 130033,China)
出处
《中华耳鼻咽喉头颈外科杂志》
CAS
CSCD
北大核心
2018年第8期628-630,共3页
Chinese Journal of Otorhinolaryngology Head and Neck Surgery
基金
国家自然科学基金（81570897）
吉林省财政厅项目（sczsy201524）
关键词
免疫疗法
淋巴结
Immunotherapy
Lymph nodes
